本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Viking Therapeutics, Inc.

41.00
+0.40000.99%
成交量:496.13萬
成交額:2.05億
市值:46.34億
市盈率:-19.34
高:43.15
開:42.09
低:40.01
收:40.60
52周最高:62.50
52周最低:18.92
股本:1.13億
流通股本:1.10億
量比:1.11
換手率:4.51%
股息:- -
股息率:- -
每股收益(TTM):-2.1195
每股收益(LYR):-1.0085
淨資產收益率:-29.23%
總資產收益率:-20.48%
市淨率:6.50
市盈率(LYR):-40.65

資料載入中...

2024/04/25

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/24

重要事件披露

Form 8-K - Current report
2024/03/26

重要事件披露

Form 8-K - Current report
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/07

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals